Hepaford tablet contains L-Ornithine L-Aspartate
L-Ornithine L-Aspartate (LOLA) converts ammonia to urea thus reduces the burden of the liver and increases functional capacity of the liver.
Hepaford tablet contain combination of L-Ornithine L-Aspartate is used for the treatment of liver dysfunctioning, or severe liver impairment. It may also be taken for high ammonia levels and in end stage renal disease.
Direction for use:
One or two Hepaford tablets three times a day, with or without food.
Use under medical supervision